Suppr超能文献

伊朗东部霍拉桑省南部乳腺癌患者基因的突变分析

Mutations analysis of gene in patients with breast cancer in South Khorasan province, East Iran.

作者信息

Khalili-Tanha Ghazaleh, Sebzari Ahmadreza, Moodi Mitra, Hajipoor Fatemeh, Naseri Mohsen

机构信息

Cellular and Molecular Research Center, Genomics research group, Birjand University of Medical Science, Birjand, Iran.

Radiation Oncologist, Clinical Research Development Unit (CRDU), Valiasr hospital Birjand University of Medical Sciences, Birjand, Iran.

出版信息

Med J Islam Repub Iran. 2019 Oct 2;33:105. doi: 10.34171/mjiri.33.105. eCollection 2019.

Abstract

Breast cancer (BC) is well-known as the most common malignancy and the first leading cause of cancer-related death among women worldwide. Evidence suggests that familial history and age are important risk factors for the development of this disease in Iran. Mutations in and genes are the cause of 5 to 10% of hereditary BC. Recent studies demonstrated that mutations in were observed in high-risk women with family histories of BC. However, to date, the mutations have not been elucidated in BC patients from east of Iran. The purpose of this study was to analyze mutations in BC patient from South Khorasan Province. In the present study, 88 BC patients (11 positive family history) were screened for mutations in . The analysis of was carried out by SSCP (single-strand conformation polymorphism) for shorter exons and direct sequencing in the case of longer ones. Twenty-eight of the patients (31.8%) had a synonymous mutation (c.4308T>C) in exon 13. A missense mutation (c. 4837A>G) was presented in exon 16 with a frequency of 56.8 %. In exon 11 three missense mutations were observed, and the frequency rate for c.3113A>G was 32.5%, for c.3119G>A was 5%, and the highest frequency belonged to c.3548A>G with 72.4% in familial BC and 45.4% in the non-familial group. In our study, five mutations were found, but none of the founder mutations were identified in this population. Two missense mutations in exon 16 (56.8%) and in exon 11 (65%) had the highest frequency in South Khorasan Province.

摘要

乳腺癌(BC)是全球女性中最常见的恶性肿瘤以及癌症相关死亡的首要原因。有证据表明,家族病史和年龄是伊朗该疾病发生的重要风险因素。BRCA1和BRCA2基因的突变是5%至10%遗传性乳腺癌的病因。最近的研究表明,在有乳腺癌家族史的高危女性中观察到了BRCA2突变。然而,迄今为止,伊朗东部乳腺癌患者中的这些突变尚未得到阐明。本研究的目的是分析南呼罗珊省乳腺癌患者中的BRCA2突变。在本研究中,对88例乳腺癌患者(11例有阳性家族史)进行了BRCA2突变筛查。对于较短的外显子,通过单链构象多态性(SSCP)分析BRCA2,对于较长的外显子则进行直接测序。28例患者(31.8%)在外显子13中有一个同义突变(c.4308T>C)。外显子16中出现了一个错义突变(c.4837A>G),频率为56.8%。在外显子11中观察到三个错义突变,c.3113A>G的频率为32.5%,c.3119G>A为5%,频率最高的是c.3548A>G,在家族性乳腺癌中为72.4%,在非家族性组中为45.4%。在我们的研究中,发现了五个突变,但在该人群中未鉴定出始祖突变。外显子16(56.8%)和外显子11(65%)中的两个错义突变在南呼罗珊省频率最高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d8b/6946920/5c77e4a784b7/mjiri-33-105-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验